YENOM NOTICIAS
Noticias financieras organizadas para conectar titulares, símbolos, fuente, fecha y sentimiento con tu análisis y operativa.
Si escribes ticker, YENOM prioriza ese instrumento. Si lo dejas vacío puedes explorar el feed general o por tema.
[Different Sizes of Empty Prescription Bottles stock photo] FatCamera/E+ via Getty Images Millions of Americans use mail-order pharmacies from Canada and other countries to personally import medication for a fraction of the U.S. cost. That…
The Invesco Pharmaceuticals ETF (NYSEMKT:PJP) concentrates specifically on a narrow group of 27 pharmaceutical companies, while the iShares U.S. Healthcare ETF (NYSEMKT:IYH) provides broader sector exposure with 100 holdings and a lower ex…
AMGEN Inc_ HQ sign- by JHVEPhoto via iStock Thousand Oaks, California-based Amgen Inc. (AMGN) is a leading biotechnology company that discovers, develops, manufactures, and delivers innovative biologic medicines for serious diseases. With…
The Invesco Pharmaceuticals ETF (NYSEMKT:PJP) provides broader pharmaceutical exposure and a higher dividend yield, while the VanEck Biotech ETF (NASDAQ:BBH) offers a more concentrated biotechnology play with a lower expense ratio. Healthc…
Both the Fidelity MSCI Health Care Index ETF (NYSEMKT:FHLC) and the Invesco Pharmaceuticals ETF (NYSEMKT:PJP) focus on the medical space, but their underlying strategies, costs, and risk profiles differ significantly for long-term portfoli…
Healthcare ETFs are hitting one-year highs because the sector is benefiting from a solid combination of improving earnings visibility, attractive relative valuations, and a rotation out of overcrowded AI/tech trades into defensive growth.…
Vanguard Health Care ETF (NYSEMKT:VHT) and Invesco Pharmaceuticals ETF (NYSEMKT:PJP) differ primarily in scope and cost, as the Vanguard fund provides broad sector coverage for a fraction of the Invesco fund price. Healthcare investors oft…
[Close-Up Shot of Scientists Hands typing Data in Laptop in Laboratory] Tom Werner Rajesh Kumar, head of European Life Sciences & Healthcare Equity Research at HSBC, positioned healthcare (XLV [https://seekingalpha.com/symbol/XLV]) as a de…
Key Points iShares Global Healthcare ETF offers broader diversification with 110 global holdings compared to 29 U.S. stocks for Invesco Pharmaceuticals ETF Invesco Pharmaceuticals ETF has a higher expense ratio of 0.57% but outperformed ov…
Invesco Pharmaceuticals ETF (NYSEMKT:PJP) offers concentrated U.S. pharma exposure, while iShares Global Healthcare ETF (NYSEMKT:IXJ) provides a more diversified, lower-cost global approach with higher assets under management and dividend…
Key Points The iShares U.S. Healthcare ETF (IYH) offers a broader portfolio with a lower expense ratio than the Invesco Pharmaceuticals ETF (PJP). PJP has delivered significantly higher total returns over the past year. IYH provides a slig…
The iShares U.S. Healthcare ETF (NYSEMKT:IYH) provides broad exposure to the medical sector at a lower cost, while the Invesco Pharmaceuticals ETF (NYSEMKT:PJP) offers a more concentrated bet on drug development. While both funds target Am…
Invesco Pharmaceuticals ETF (NYSEMKT:PJP) offers a less volatile, concentrated pharmaceutical focus with higher yield, whereas State Street SPDR S&P Biotech ETF (NYSEMKT:XBI) provides high-growth, equal-weighted biotechnology exposure at a…
Key Points Invesco Pharmaceuticals ETF offers a higher dividend yield and lower five-year beta than State Street SPDR S&P Biotech ETF State Street SPDR S&P Biotech ETF holds 155 securities compared to 30 in Invesco Pharmaceuticals ETF Inve…
The iShares U.S. Pharmaceuticals ETF (NYSEMKT:IHE) offers lower fees and a higher dividend yield, while the Invesco Pharmaceuticals ETF (NYSEMKT:PJP) spreads its holdings more evenly across the sector's biggest players. Investors seeking p…
Key Points The VanEck Pharmaceutical ETF provides a lower expense ratio and a more substantial dividend yield than the Invesco Pharmaceuticals ETF. The Invesco Pharmaceuticals ETF delivered higher 1-year total returns but has lagged the Va…
The VanEck Pharmaceutical ETF (NASDAQ:PPH) offers a more cost-efficient entry point and higher income potential, while the Invesco Pharmaceuticals ETF (NYSEMKT:PJP) has recently demonstrated stronger price appreciation for investors seekin…
Key Points State Street Health Care Select Sector SPDR ETF offers a significantly lower expense ratio and far greater assets under management than Invesco Pharmaceuticals ETF. Invesco's ETF focuses exclusively on 29 pharmaceutical companie…
The State Street Health Care Select Sector SPDR ETF (NYSEMKT:XLV) provides broad, low-cost exposure to the entire healthcare sector, whereas the Invesco Pharmaceuticals ETF (NYSEMKT:PJP) offers a concentrated bet on 29 specific pharmaceuti…
Designed to provide broad exposure to the Healthcare - Pharma segment of the equity market, the Invesco Pharmaceuticals ETF (PJP) is a passively managed exchange traded fund launched on June 23, 2005. While an excellent vehicle for long te…
Weight loss drug advances, including GLP-1s, have revolutionized health care. For investors looking to capitalize on the GLP-1 trend, two funds are worth considering. The Invesco S&P 500 Equal Weight Health Care ETF (NYSEMKT:RSPH) offers a…
Key Points Invesco Pharmaceuticals ETF has a significantly lower five-year maximum drawdown and lower volatility profile than State Street SPDR S&P Biotech ETF State Street SPDR S&P Biotech ETF offers a more diversified approach with 151 h…
[100 US dollar note on a USA flag with word TARIFFS] Tomas Ragina/iStock via Getty Images Approximately $20.6B is on its way to importers who successfully filed claims using the new web portal developed by US Customs and Border Protection,…
Amgen Inc. (AMGN), headquartered in Thousand Oaks, California, discovers, develops, manufactures, and delivers human therapeutics. With a market cap of $182.4 billion, the company focuses on human therapeutics and concentrates on innovatin…
Designed to provide broad exposure to the Healthcare - Pharma segment of the equity market, the Invesco Pharmaceuticals ETF (PJP) is a passively managed exchange traded fund launched on June 23, 2005. Passively managed ETFs are becoming in…
The Invesco Pharmaceuticals ETF (PJP) was launched on June 23, 2005, and is a passively managed exchange traded fund designed to offer broad exposure to the Healthcare - Pharma segment of the equity market. Passively managed ETFs are becom…
[Young female scientist working in laboratory] Solskin Pharmaceutical (PJP [https://seekingalpha.com/symbol/PJP]), (XPH [https://seekingalpha.com/symbol/XPH]), (PPH [https://seekingalpha.com/symbol/PPH]) and biotechnology stocks (XBI [http…
[Data particle around the Earth which with stock charts in cyber space] Hiroshi Watanabe UBS’s global equity strategy team published a list of 10 ideas challenging consensus views and identifying where core forecasts might miss the mark. I…
Looking for broad exposure to the Healthcare - Pharma segment of the equity market? You should consider the iShares U.S. Pharmaceuticals ETF (IHE), a passively managed exchange traded fund launched on May 1, 2006. While an excellent vehicl…
In the latest installment of Yahoo Finance's ETF Report, CFRA Research Head of ETF Research Aniket Ullal sits down with Yahoo Finance markets and data editor Jared Blikre to talk about why he is favoring pharmaceutical and biotech funds —…
The Invesco Pharmaceuticals ETF (PJP) was launched on June 23, 2005, and is a passively managed exchange traded fund designed to offer broad exposure to the Healthcare - Pharma segment of the equity market. An increasingly popular option a…
At the onset of this month, the UK and U.S. governments signed a landmark pharmaceuticals trade deal aimed at rebalancing transatlantic commerce and securing access to innovative medicines. The core of the agreement is a straightforward ex…
[Close-up of a male hand holding a pill bottle pouring medication into his hand] Trevor Williams The recent news [https://seekingalpha.com/news/4525254-novo-nordisk-slides-as-ozempic-pill-fails-to-slow-alzheimers-disease-progression-in-lar…
The third-quarter results of the broader Medical sector, which includes major large-cap pharmaceutical companies, have been quite impressive this year, with more than 82% of sector participants having reported so far. These stocks posted a…
Pharma giants Eli Lily (LLY) and Novo Nordisk (NVO) have signed deals with U.S. President Donald Trump to slash the prices of some of their obesity drugs, including upcoming pills, as per a White House announcement made late last week. Thi…
If you're interested in broad exposure to the Healthcare - Pharma segment of the equity market, look no further than the Invesco Pharmaceuticals ETF (PJP), a passively managed exchange traded fund launched on June 23, 2005. An increasingly…